-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
GoodRx Holdings, Inc. annual Deferred Federal Income Tax Expense (Benefit) history and growth rate from 2018 to 2023.
- GoodRx Holdings, Inc. annual Deferred Federal Income Tax Expense (Benefit) for 2023 was -$41.9M, a 9842% decline from 2022.
- GoodRx Holdings, Inc. annual Deferred Federal Income Tax Expense (Benefit) for 2022 was -$421K, a 106% decline from 2021.
- GoodRx Holdings, Inc. annual Deferred Federal Income Tax Expense (Benefit) for 2021 was $6.52M.
Deferred Federal Income Tax Expense (Benefit), Annual (USD)
Deferred Federal Income Tax Expense (Benefit), YoY Annual Growth (%)